Skip to content

High Definition Neuromuscular Stimulation in Tetraplegia

High Definition Neuromuscular Stimulation in Tetraplegia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04075812
Enrollment
2
Registered
2019-09-03
Start date
2013-04-25
Completion date
2019-06-21
Last updated
2021-08-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Cord Injury at C4-C6 Level

Keywords

reanimation, stimulation

Brief summary

The purpose of this study is to demonstrate high definition non-invasive neuromuscular stimulation of an upper extremity in tetraplegic participants.

Detailed description

Spinal cord injury (SCI) is an insult to the spinal cord resulting in a change, either temporary or permanent, in its normal motor, sensory, and/or autonomic function. It is estimated that the annual incidence of spinal cord injury (SCI), not including those who die at the scene of the accident, is approximately 40 cases per million population in the U. S. or approximately 12,000 new cases each year. The purpose of this study is to demonstrate high definition non-invasive neuromuscular stimulation of an upper extremity in tetraplegic participants. This study will plan to enroll up to 15 subjects who have been diagnosed with tetraplegia. The total duration of the study is expected to be about 18 months, and each participant is expected to be on the study for about 6 months. The study design will consist of the following two (2) phases listed below. I. Baseline assessment and calibration (approximately 1 month) II. Testing motions: pre-sequenced and EEG-triggered motions; further calibration as needed (approximately 5 months) Phase I - Baseline * Medical history review * Physical and neurological exam * EMG * Fit and calibrate external stimulator: The Battelle Neuromuscular Stimulator will be setup and calibrated to evoke wrist and hand/finger movements. Phase II - Testing Motions After the Neuromuscular Stimulator is setup and calibrated, various spatial and temporal stimulation patterns will be tested to evoke wrist/hand movements in various sequences of individual and combined movements.

Interventions

DEVICENeuromuscular Stimulator

Sponsors

Ohio State University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Intervention model description

Single arm, open-label, non-controlled prospective intervention

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Must be 21 years or older. * Must be tetraplegic (C4-6 ASIA A) * 12 months post injury and neurologically stable * Participant is willing to comply with all follow-up evaluations at the specified times. * Participant is able to provide informed consent prior to enrollment in the study. * The participant is fluent in English.

Exclusion criteria

* No active wound healing or skin breakdown issues. * No history of poorly controlled autonomic dysreflexia. * Other implantable devices such as heart/brain pacemakers * Subjects who rely on ventilators

Design outcomes

Primary

MeasureTime frameDescription
Change in Voluntary Movementthrough study completion, up to 60 monthsconsistent and repetitive voluntary movement in the targeted muscle groups as assessed by investigator(s)- no formal scale is used. The participant(s) started out with paralysis due to spinal cord injury, so any active voluntary movement consists of a qualitative change in movement.

Secondary

MeasureTime frameDescription
Change in Functional Movementthrough study completion, up to 60 monthsconsistent movement in the targeted muscle groups that is functional (manipulate or pick up an object); as assessed by investigator(s) for task completion- no formal scale used Objects were taken from the Action Research Arm Task, Grasp and Release Task, GRASSP as well as using household objects (phone, cup, spoon)

Countries

United States

Participant flow

Recruitment details

Recruited from Tertiary Care Center

Participants by arm

ArmCount
Neuromuscular Stimulator
Neuromuscular Stimulator is setup and calibrated, various spatial and temporal stimulation patterns will be tested to evoke wrist/hand movements in various sequences of individual and combined movements. Neuromuscular Stimulator
2
Total2

Baseline characteristics

CharacteristicNeuromuscular Stimulator
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
2 Participants
Age, Continuous31 years
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
2 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
0 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
2 Participants
Region of Enrollment
United States
2 participants
Sex: Female, Male
Female
1 Participants
Sex: Female, Male
Male
1 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 2
other
Total, other adverse events
2 / 2
serious
Total, serious adverse events
1 / 2

Outcome results

Primary

Change in Voluntary Movement

consistent and repetitive voluntary movement in the targeted muscle groups as assessed by investigator(s)- no formal scale is used. The participant(s) started out with paralysis due to spinal cord injury, so any active voluntary movement consists of a qualitative change in movement.

Time frame: through study completion, up to 60 months

Population: All enrolled patients were able to generate consistent and repetitive movement in targeted muscle groups

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Neuromuscular StimulatorChange in Voluntary MovementEvoked movement - able2 Participants
Neuromuscular StimulatorChange in Voluntary MovementEvoked movement - unable0 Participants
Secondary

Change in Functional Movement

consistent movement in the targeted muscle groups that is functional (manipulate or pick up an object); as assessed by investigator(s) for task completion- no formal scale used Objects were taken from the Action Research Arm Task, Grasp and Release Task, GRASSP as well as using household objects (phone, cup, spoon)

Time frame: through study completion, up to 60 months

Population: Consistent functional movement for object manipulation

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Neuromuscular StimulatorChange in Functional MovementEvoked object manipulation - able2 Participants
Neuromuscular StimulatorChange in Functional MovementEvoked object manipulation - unable0 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026